Usefulness of qualitative polymerase chain reaction for Trypanosoma cruzi DNA in endomyocardial biopsy specimens of chagasic heart transplant patients
Nenhuma Miniatura disponível
Citações na Scopus
10
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Autores
Citação
JOURNAL OF HEART AND LUNG TRANSPLANTATION, v.30, n.7, p.799-804, 2011
Resumo
BACKGROUND: Chagas' disease reactivation (CDR) after heart transplantation is characterized by relapse of the infectious disease, with direct detection of Trypanosoma cruzi parasites in blood, cerebrospinal fluid, or tissues. CDR affecting the myocardium induces lymphocytic myocarditis and should be distinguished from acute cellular rejection in endomyocardial biopsy (EMB) specimens. METHODS: We performed retrospectively qualitative polymerase chain reaction for T cruzi DNA using 2 sets of primers targeting nuclear DNA (nDNA) or kinetoplast DNA (kDNA) in 61 EMB specimens of 11 chagasic heart transplant recipients who presented with CDR. Thirty-five EMB specimens were obtained up to 6 months before (pre-CDR group) and 26 up to 2 years after the diagnosis of CDR. The control group consisted of 6 chagasic heart transplant recipients with 18 EMB specimens who never experienced CDR. RESULTS: Amplification of kDNA occurred in 8 of 35 (22.9%) EMB specimens of the pre-CDR group, in 5 of 18(27.8%) of the control group, and in 17 of 26(65.4%) EMB specimens obtained after the successful treatment of CDR. Amplification of nDNA occurred in 3 of 35 (8.6%) EMB specimens of the pre-CDR group, 0 of 18 (0%) of the control group, and 6 of 26 (23.1%) EMB specimens obtained after the successful treatment of CDR. CONCLUSIONS: Amplification of kDNA in EMB specimens is not specific for the diagnosis of CDR, occurring also in patients with no evidence of CDR (control group). However, amplification of nDNA occurred in a few EMB specimens obtained before CDR, but in none of the control group specimens. Qualitative PCR for T cruzi DNA in EMB specimens should not be used as a criterion for cure of CDR because it can persist positive despite favorable clinical evolution of the patients. J Heart Lung Transplant 2011;30:799-804 (C) 2011 International Society for Heart and Lung Transplantation. All rights reserved.
Palavras-chave
Chagas' disease, Trypanosoma cruzi, heart transplantation, endomyocardial biopsy, polymerase chain reaction
Referências
- Bocchi EA, 2001, ANN THORAC SURG, V71, P1833, DOI 10.1016/S0003-4975(01)02587-5
- Bacal F, 2010, CLIN TRANSPLANT, V24, pE29, DOI 10.1111/j.1399-0012.2009.01202.x
- Palomino SAP, 2000, ANN TROP MED PARASIT, V94, P571
- Maldonado C, 2004, J HEART LUNG TRANSPL, V23, P1345, DOI 10.1016/j.healun.2003.09.027
- WINCKER P, 1994, AM J TROP MED HYG, V51, P771
- Diez M, 2007, AM J TRANSPLANT, V7, P1633, DOI 10.1111/j.1600-6143.2007.01820.x
- Sartori AMC, 1998, AM J TROP MED HYG, V59, P784
- Bocchi EA, 1996, ANN THORAC SURG, V61, P1727, DOI 10.1016/0003-4975(96)00141-5
- JONES EM, 1993, AM J TROP MED HYG, V48, P348
- Campos SV, 2008, J HEART LUNG TRANSPL, V27, P597, DOI 10.1016/j.healun.2008.02.017
- Benvenuti LA, 2005, CARDIOVASC PATHOL, V14, P265, DOI 10.1016/j.carpath.2005.06.001
- Benvenuti LA, 2008, ANN TROP MED PARASIT, V102, P481, DOI 10.1179/136485908X311740
- Godoy HL, 2010, J HEART LUNG TRANSPL, V29, P286, DOI 10.1016/j.healun.2009.08.006
- Higuchi MD, 2003, CARDIOVASC RES, V60, P96, DOI 10.1016/S0008-6363(03)00361-4
- Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296
- Olivares-Villagomez D, 1998, AM J TROP MED HYG, V59, P563
- Ribeiro-Dos-Santos G, 1999, ANN TROP MED PARASIT, V93, P689, DOI 10.1080/00034989957934
- Schijman AG, 2000, J HEART LUNG TRANSPL, V19, P1114, DOI 10.1016/S1053-2498(00)00168-6